![Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13075-019-1879-x/MediaObjects/13075_2019_1879_Fig1_HTML.png)
Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an
PLOS Medicine: Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
![FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial | British Journal of Cancer FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41416-020-01140-9/MediaObjects/41416_2020_1140_Fig2_HTML.png)
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial | British Journal of Cancer
A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference
![Predicting the Placebo response in OA to Improve the Precision of the Treatment Effect Estimation - Tools4Patient Predicting the Placebo response in OA to Improve the Precision of the Treatment Effect Estimation - Tools4Patient](https://www.tools4patient.com/wp-content/uploads/2021/04/Screenshot-2021-04-30-at-08.42.48.png)
Predicting the Placebo response in OA to Improve the Precision of the Treatment Effect Estimation - Tools4Patient
![Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/e7d31c91-9c6a-4ecc-87eb-2074454af216/gr1a.jpg)
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases
![CONSORT diagram. Composition of the per protocol population with sleep... | Download Scientific Diagram CONSORT diagram. Composition of the per protocol population with sleep... | Download Scientific Diagram](https://www.researchgate.net/publication/334322194/figure/fig1/AS:789711450800130@1565293290786/CONSORT-diagram-Composition-of-the-per-protocol-population-with-sleep-study-data-through.png)
CONSORT diagram. Composition of the per protocol population with sleep... | Download Scientific Diagram
PLOS ONE: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia
![CONSORT Flow Diagram. *Per protocol population was used for applicable... | Download Scientific Diagram CONSORT Flow Diagram. *Per protocol population was used for applicable... | Download Scientific Diagram](https://www.researchgate.net/publication/296624572/figure/fig3/AS:340879995883562@1458283532884/CONSORT-Flow-Diagram-Per-protocol-population-was-used-for-applicable-efficacy-PK-and.png)
CONSORT Flow Diagram. *Per protocol population was used for applicable... | Download Scientific Diagram
![Supplemental Materials for Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with intermediate and advanced stage hepatocellular carcinoma: A phase II, single-arm, prospective study - European Journal of Cancer Supplemental Materials for Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with intermediate and advanced stage hepatocellular carcinoma: A phase II, single-arm, prospective study - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d0ac352b-c604-41c4-8d69-fbe990fcdb5c/gr1_lrg.jpg)
Supplemental Materials for Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with intermediate and advanced stage hepatocellular carcinoma: A phase II, single-arm, prospective study - European Journal of Cancer
![Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial - Clinical Microbiology and Infection Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial - Clinical Microbiology and Infection](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/fc3b7977-9074-49e0-a3e1-aa41b0bef3b7/gr1.jpg)
Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial - Clinical Microbiology and Infection
![A randomized, double‐blind, placebo‐controlled trial to evaluate the efficacy, safety, and tolerability of long‐term treatment with prucalopride - Piessevaux - 2015 - Neurogastroenterology & Motility - Wiley Online Library A randomized, double‐blind, placebo‐controlled trial to evaluate the efficacy, safety, and tolerability of long‐term treatment with prucalopride - Piessevaux - 2015 - Neurogastroenterology & Motility - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a8c3e77a-5a5c-4487-b739-e24671e97bed/nmo12553-fig-0002-m.png)
A randomized, double‐blind, placebo‐controlled trial to evaluate the efficacy, safety, and tolerability of long‐term treatment with prucalopride - Piessevaux - 2015 - Neurogastroenterology & Motility - Wiley Online Library
![Discordance between reported intention-to-treat and per protocol analyses - Journal of Clinical Epidemiology Discordance between reported intention-to-treat and per protocol analyses - Journal of Clinical Epidemiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2006274486/2028398056/gr1.jpg)
Discordance between reported intention-to-treat and per protocol analyses - Journal of Clinical Epidemiology
![New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial - The Lancet Infectious Diseases New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/b922c7ec-4dc5-4390-91c0-36cccc2436a6/gr1.jpg)